We are advising Mallinckrodt plc, a global leader in specialty pharmaceuticals, on its $6.7 billion merger with Endo, Inc.

The team is led by Stephen Ranalow, Maeve Moran and Niamh O’Toole (Corporate and M&A) and includes Fintan Clancy and Orlaith Kane, (Tax), and David Molloy (Debt Finance).

Our team included Amina Flynn, Niamh O’Driscoll, Glyn McCormack, Eimear Gallagher, Sydney O’Shea and Sondos Siddiqi (Corporate and M&A), Dearbhla Ní Fhloinn and Ciara Murphy (Tax), Adrianna Keenan and Suzanne Connell (Debt Finance), Patrick Horan, and Ailbhe Ó Faoláin (Competition and Regulated Markets).

For more information, please visit the Mallinckrodt website.